Schizophrenia News and Research

Latest Schizophrenia News and Research

Study reports new links between brain cell activity and choices where two options have equal appeal

Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great interest to economists, who have devised theories about how we assign values to our options and use those values to make decisions.

6 Dec 2013

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

5 Dec 2013

Cognitive performance in psychosis has roots in childhood

The cognitive performance of patients with first-episode psychosis is not related to how long psychosis or other psychiatric symptoms have remained untreated, say researchers.

5 Dec 2013

Social defeat links past trauma to current psychosis

The feeling of social defeat may be responsible for the link between childhood trauma and psychosis, research suggests.

3 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Childhood asthma, eczema linked to adolescent psychotic experiences

UK research indicates that children with asthma and eczema are significantly more likely to have psychotic experiences during adolescence, boosting a previously reported relationship between schizophrenia and atopic disorders.

28 Nov 2013

Substance use does not predict schizophrenia self-harm, violence

Substance misuse, although common among people with schizophrenia, does not heighten their risk for self-harm or violence, study findings show.

28 Nov 2013

Research: Modification of SUMO protein plays vital role in normal brain function

Scientists are a step closer to understanding how some of the brain's 100 billion nerve cells co-ordinate their communication.

28 Nov 2013

Cognitive impairment predates psychosis onset

People at clinical or familial risk for schizophrenia have similar cognitive deficits to those in patients with first-episode schizophrenia, a study shows.

26 Nov 2013

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Brian K. Kaspar, PhD, and Veronica J. Vieland, PhD, principal investigators in The Research Institute at Nationwide Children's Hospital, have been named Fellows of the American Association for the Advancement of Science (AAAS).

26 Nov 2013

Research: Smallest parts of brain play crucial role in decision making

One of the smallest parts of the brain is getting a second look after new research suggests it plays a crucial role in decision making.

25 Nov 2013

New targeted treatments for autism may be possible

Finding major new clues to the origins of autism, a Yale-led team of researchers has pinpointed which cell types and regions of the developing human brain are affected by gene mutations linked to autism. They report their findings in the Nov. 21 issue of the journal Cell.

22 Nov 2013

Treatment key to averting psychosis violence after prison release

The risk for violence after the release of prisoners with sexual or violent offences is increased if they have untreated psychosis, a study shows.

21 Nov 2013

Released prisoners with schizophrenia three times more likely to be violent than other prisoners

New research from Queen Mary University of London shows released prisoners with schizophrenia are three times more likely to be violent than other prisoners, but only if they receive no treatment or follow-up support from mental health services.

21 Nov 2013

Childhood social functioning predicts schizophrenia risk

Poor social functioning in childhood predicts an increased risk for schizophrenia later in life, suggest researchers.

20 Nov 2013

Omeros’ OMS302 reduces incidence of miosis during intraocular lens replacement in Phase 3 clinical trial

Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.

20 Nov 2013

Non-specialist health workers provide treatment for people with MNS problems in developing countries

Non-specialist health workers are beneficial in providing treatment for people with mental, neurological and substance-abuse (MNS) problems in developing countries - where there is often a lack of mental health professionals - according to a new Cochrane review.

20 Nov 2013

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

Investigators at The Feinstein Institute for Medical Research have discovered a new genetic risk factor for schizophrenia and bipolar disorder called NDST3. The findings are published online in Nature Communications.

20 Nov 2013

Cerebral basis for positive psychosis symptoms pinpointed

Altered activation in the secondary somatosensory cortex during sensorimotor experiences may underlie the flawed judgments resulting in positive schizophrenia symptoms, research suggests.

19 Nov 2013

Researchers develop novel system to image worm brain activity

A research team at Worcester Polytechnic Institute and The Rockefeller University in New York has developed a novel system to image brain activity in multiple awake and unconstrained worms. The technology, which makes it possible to study the genetics and neural circuitry associated with animal behavior, can also be used as a high-throughput screening tool for drug development targeting autism, anxiety, depression, schizophrenia, and other brain disorders.

18 Nov 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Study reports new links between brain cell activity and choices where two options have equal appeal

Researchers identify gene involved in building circuitry that relays signals via brain

Cognitive performance in psychosis has roots in childhood

Social defeat links past trauma to current psychosis

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Childhood asthma, eczema linked to adolescent psychotic experiences

Substance use does not predict schizophrenia self-harm, violence

Research: Modification of SUMO protein plays vital role in normal brain function

Cognitive impairment predates psychosis onset

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Research: Smallest parts of brain play crucial role in decision making

New targeted treatments for autism may be possible

Treatment key to averting psychosis violence after prison release

Released prisoners with schizophrenia three times more likely to be violent than other prisoners

Childhood social functioning predicts schizophrenia risk

Omeros’ OMS302 reduces incidence of miosis during intraocular lens replacement in Phase 3 clinical trial

Non-specialist health workers provide treatment for people with MNS problems in developing countries

Researchers discover new genetic risk factor for schizophrenia, bipolar disorder

Cerebral basis for positive psychosis symptoms pinpointed

Researchers develop novel system to image worm brain activity

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Schizophrenia News and Research

Latest Schizophrenia News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in